Tim Xiao
Directeur/Membre du Conseil chez Oncomyx Therapeutics, Inc.
Profil
Tim Xiao is currently a Director at Sichuan Clover Biopharmaceuticals, Inc and Oncomyx Therapeutics, Inc. He is also a Board Member at STRM.Bio, Inc. In the past, he served as a Non-Executive Director at Clover Biopharmaceuticals Ltd.
and as a Board Member at Thermalin, Inc. and Luqa Pharmaceuticals Co., Ltd.
Mr. Xiao holds an undergraduate degree from Shanghai Jiao Tong University, which he obtained in 2008.
Postes actifs de Tim Xiao
Sociétés | Poste | Début |
---|---|---|
Oncomyx Therapeutics, Inc.
Oncomyx Therapeutics, Inc. Packaged SoftwareTechnology Services Oncomyx Therapeutics, Inc. develops and operates software platform to orchestrate an immune response and treat cancer. Its platform's features include non-human pathogen, immuno-stimulatory, ability to multi-arm, and systemic delivery. The company was founded by Steve Potts, Michael Wood, Grant McFadden and is headquartered in Phoenix, AZ. | Directeur/Membre du Conseil | - |
Delos Advisors Ltd.
Delos Advisors Ltd. Investment ManagersFinance Delos Advisors Ltd (Delos Capital) is a private equity and venture capital firm founded by Lin Zheng Chen in 2014. The firm is headquartered in Hong Kong. | Private Equity Investor | 01/01/2014 |
Sichuan Clover Biopharmaceuticals, Inc
Sichuan Clover Biopharmaceuticals, Inc Pharmaceuticals: MajorHealth Technology Sichuan Clover Biopharmaceuticals, Inc is a clinical-stage biotechnology company based in Chengdu, China. Clover Biopharmaceuticals' mission is to leverage their trimer-tag technology and in-house manufacturing capabilities to develop and deliver innovative and affordable medical solutions. The Chinese company is committed to partnering with leading healthcare organizations to advance their breakthrough pipeline programs and deliver them to patients. The company's pipeline includes many vaccine and therapeutic candidates for the treatment of infectious disease, cancer, and autoimmune disease, created using trimer-tag platform technology. The company was founded in 2007 by Peng Liang, and Joshua Liang has been the CEO of the company since 2016. | Directeur/Membre du Conseil | 17/10/2019 |
Allecra Therapeutics GmbH
Allecra Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Allecra Therapeutics GmbH focuses on the development of novel treatments to combat multi drug-resistant bacterial infections. The firm serves the bio and pharmaceutical industry. The company was founded by Nicholas Benedict and Stuart Shapiro in 2013 and is headquartered in Weil am Rhein, Germany. | Directeur/Membre du Conseil | 01/06/2016 |
Intrinsic Therapeutics, Inc.
Intrinsic Therapeutics, Inc. Medical SpecialtiesHealth Technology Intrinsic Therapeutics, Inc. develops device-based therapies for soft-tissue injuries of the spine. It offers surgeons and patients better options for treating painful disc herniations that cause sciatica and low back pain. The company was founded by Gregory H. Lambrecht in 1999 and is headquartered in Woburn, MA. | Directeur/Membre du Conseil | 01/05/2017 |
STRM.Bio, Inc.
STRM.Bio, Inc. BiotechnologyHealth Technology STRM.Bio, Inc. is a pre-clinical biotechnology company based in Cambridge, MA. The company's goal is to make gene therapy safe for repeat dosing and to provide a future of medicine for patients with rare diseases worldwide. The company, which was founded by Jonathan Thon and has had him as CEO since incorporation, is backed by venture capital and focuses on developing and delivering targeted gene therapies using extracellular vesicles. | Directeur/Membre du Conseil | 01/04/2021 |
Delos Capital LLC
Delos Capital LLC Investment ManagersFinance Delos Capital LLC (Delos Capital) is a private equity firm founded in 2013 by Mattew Constantino. The firm is headquartered in New York. | Private Equity Investor | 01/12/2014 |
Anciens postes connus de Tim Xiao
Sociétés | Poste | Fin |
---|---|---|
CLOVER BIOPHARMACEUTICALS, LTD. | Directeur/Membre du Conseil | 22/04/2022 |
Luqa Pharmaceuticals Co., Ltd.
Luqa Pharmaceuticals Co., Ltd. Household/Personal CareConsumer Non-Durables Luqa Pharmaceuticals operates as a pharmaceutical company, acquires, develops, and commercializes healthcare products. It offers products for derma and aesthetics that include Ebernet, an eberconazole cream for the treatment of fungal infections of the skin; and Strataderm, a silicone gel formulation for the treatment of old and new scars, as well as abnormal scar prevention in the form of hypertrophic scars and keloids. The company was founded by Luo Beiwei in 2010 and is headquartered in Shanghai, China. | Directeur/Membre du Conseil | 01/02/2021 |
░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Tim Xiao
Shanghai Jiao Tong University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
CLOVER BIOPHARMACEUTICALS, LTD. | Health Technology |
Entreprise privées | 9 |
---|---|
Oncomyx Therapeutics, Inc.
Oncomyx Therapeutics, Inc. Packaged SoftwareTechnology Services Oncomyx Therapeutics, Inc. develops and operates software platform to orchestrate an immune response and treat cancer. Its platform's features include non-human pathogen, immuno-stimulatory, ability to multi-arm, and systemic delivery. The company was founded by Steve Potts, Michael Wood, Grant McFadden and is headquartered in Phoenix, AZ. | Technology Services |
Delos Advisors Ltd.
Delos Advisors Ltd. Investment ManagersFinance Delos Advisors Ltd (Delos Capital) is a private equity and venture capital firm founded by Lin Zheng Chen in 2014. The firm is headquartered in Hong Kong. | Finance |
Sichuan Clover Biopharmaceuticals, Inc
Sichuan Clover Biopharmaceuticals, Inc Pharmaceuticals: MajorHealth Technology Sichuan Clover Biopharmaceuticals, Inc is a clinical-stage biotechnology company based in Chengdu, China. Clover Biopharmaceuticals' mission is to leverage their trimer-tag technology and in-house manufacturing capabilities to develop and deliver innovative and affordable medical solutions. The Chinese company is committed to partnering with leading healthcare organizations to advance their breakthrough pipeline programs and deliver them to patients. The company's pipeline includes many vaccine and therapeutic candidates for the treatment of infectious disease, cancer, and autoimmune disease, created using trimer-tag platform technology. The company was founded in 2007 by Peng Liang, and Joshua Liang has been the CEO of the company since 2016. | Health Technology |
Thermalin, Inc.
Thermalin, Inc. Pharmaceuticals: MajorHealth Technology Thermalin, Inc. engages in the development of insulin products for patients with diabetes. It offers stabilized, ultra-rapid, and highly concentrated; no refrigeration basal and mix; glucose-responsive smart basal; and StampPump insulins. The company was founded by Michael A. Weiss, Bruce H. Frank, and Richard Berenson in 2010 and is headquartered in Cleveland, OH. | Health Technology |
Luqa Pharmaceuticals Co., Ltd.
Luqa Pharmaceuticals Co., Ltd. Household/Personal CareConsumer Non-Durables Luqa Pharmaceuticals operates as a pharmaceutical company, acquires, develops, and commercializes healthcare products. It offers products for derma and aesthetics that include Ebernet, an eberconazole cream for the treatment of fungal infections of the skin; and Strataderm, a silicone gel formulation for the treatment of old and new scars, as well as abnormal scar prevention in the form of hypertrophic scars and keloids. The company was founded by Luo Beiwei in 2010 and is headquartered in Shanghai, China. | Consumer Non-Durables |
Allecra Therapeutics GmbH
Allecra Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Allecra Therapeutics GmbH focuses on the development of novel treatments to combat multi drug-resistant bacterial infections. The firm serves the bio and pharmaceutical industry. The company was founded by Nicholas Benedict and Stuart Shapiro in 2013 and is headquartered in Weil am Rhein, Germany. | Health Technology |
Intrinsic Therapeutics, Inc.
Intrinsic Therapeutics, Inc. Medical SpecialtiesHealth Technology Intrinsic Therapeutics, Inc. develops device-based therapies for soft-tissue injuries of the spine. It offers surgeons and patients better options for treating painful disc herniations that cause sciatica and low back pain. The company was founded by Gregory H. Lambrecht in 1999 and is headquartered in Woburn, MA. | Health Technology |
STRM.Bio, Inc.
STRM.Bio, Inc. BiotechnologyHealth Technology STRM.Bio, Inc. is a pre-clinical biotechnology company based in Cambridge, MA. The company's goal is to make gene therapy safe for repeat dosing and to provide a future of medicine for patients with rare diseases worldwide. The company, which was founded by Jonathan Thon and has had him as CEO since incorporation, is backed by venture capital and focuses on developing and delivering targeted gene therapies using extracellular vesicles. | Health Technology |
Delos Capital LLC
Delos Capital LLC Investment ManagersFinance Delos Capital LLC (Delos Capital) is a private equity firm founded in 2013 by Mattew Constantino. The firm is headquartered in New York. | Finance |